Accessibility Statement
An image of a man and woman standing outside in a field.

Alzheimer's

Picture a person living with Alzheimer’s disease. Many living with the disease may not be who you’re imagining. Alzheimer’s can look like anyone you know—your neighbor, uncle, co-worker, friend. Many with early-stage Alzheimer’s are still working, enjoying trips and sharing quality time with family. They’re still living independent lives. That’s valuable time to prolong as much as possible.​

Living a New Normal

Allan's optimistic spirit remains even after his Alzheimer's diagnosis. He's making the most of his new normal by spending quality time with family doing the activities he loves.

Time is Worth Fighting For


Alzheimer's disease progresses slowly over 10-20 years.1,2 During that time, people can have a spectrum of symptoms, from non-symptomatic (preclinical) Alzheimer’s to severe dementia.3 As the disease progresses, Alzheimer’s impacts day-to-day life more and more. It interferes with a person’s routines, relationships, hobbies and, ultimately, their independence.

The scientific advancements that are emerging, and on the horizon, require a timely, accurate diagnosis. At the first sign of changes in memory or thinking, people should see their doctor for an assessment. If someone is diagnosed too late, that can impact the potential effectiveness of approved treatment options.

You can learn more and sign up to receive updates on memory and thinking issues at morethannormalaging.lilly.com.

Don't Forget

Innovation takes decades of persistence, but we’re making progress in Alzheimer’s disease. Watch our latest film.

Scientific Advancements Have Potential to Provide New Hope


People living with Alzheimer’s don’t have time to waste. We’re taking on Alzheimer’s from every angle: advancing the science that could lead to breakthrough therapies; discovering new ways to find timely and accurate diagnoses; and partnering across our industry and beyond to work with more speed.

Through ongoing clinical trials and cutting-edge research, we’re urgently developing potential treatments and tools to help slow disease progression. It’s all with the hope to give people something invaluable: more options that could potentially provide more time.


Better Access, More Possibilities


While we’re not where we want to be—with a cure for Alzheimer’s disease—we’re making significant progress. Science has advanced to provide better diagnostic tools and treatments. But we also need this innovation to reach people living with Alzheimer’s.

That means healthcare providers need to have conversations sooner to better check for signs and symptoms of the disease. People need access to the tools that help accurately diagnose their problems with memory and thinking and the potential causes. And people living with Alzheimer’s and their families need to have appropriate reimbursements for the tools and approved treatments that may provide them more quality time.

It’s crucial for stakeholders—industry, government, healthcare, and advocates—to work together to strengthen our system’s capacity to address these issues.

Additional Resources



1. Centers for Disease Control and Prevention. Alzheimer’s Disease and Related Dementias. Available at: https://www.cdc.gov/aging/aginginfo/alzheimers.htm. Accessed February 13, 2024.

2. Porsteinsson AP, Isaacson RS, Knox S, et al. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371-386.

3. Aisen PS, Cummings J, Jack CR, et al. On the path to 2025: understanding the Alzheimer’s disease continuum. Alz Res Therapy 2017;9(1):60. https://doi.org/10.1186/s13195-017-0283-5

4. Galvin JE, Aisen P, Langbaum JB, et al. Early stages of Alzheimer’s disease: evolving the care team for optimal patient management. Front Neurol. 2021;11:592302.